Instil Bio Inc. (TIL) Stock Analysis

Instil Bio Inc. (TIL) is a publicly traded company in the HEALTHCARE sector. It trades at $8.11, carries a market capitalization of $54.73M. This page summarizes the public market data, fundamentals, and frequently asked questions for TIL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.11
• Market Cap: $54.73M
• EPS: $-7.00
• 52-Week High: $42.79
• 52-Week Low: $5.67

Market Sentiment

Instil Bio Inc. currently has a Bullish sentiment score of 0.28.

About Instil Bio Inc.

Instil Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Dallas, Texas, dedicated to pioneering advanced cell therapies for cancer treatment. The company is focused on developing its proprietary tumor-infiltrating lymphocyte (TIL) therapies, which are designed to enhance the immune system's ability to combat various malignancies. With a robust pipeline and a commitment to personalized immunotherapy, Instil Bio is strategically positioned to address significant unmet med...

GNG Research Analysis

GNG Research scores Instil Bio Inc. (TIL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TIL.

Frequently Asked Questions

Does TIL pay dividends?

Instil Bio Inc. (TIL) does not currently pay a regular dividend.

What is TIL's market cap?

Instil Bio Inc. (TIL) has a market capitalization of $54.73M with a current stock price of $8.11.